Exagen Capital Expenditures (CapEx) Growth & History (XGN)
Exagen's capital expenditures (capex) was $641,000 for fiscal 2025.
View full Exagen company overviewExagen annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $641,000 | $126,000 | +24.47% |
| 2024 | 2024-12-31 | $515,000 | −$313,000 | −37.80% |
| 2023 | 2023-12-31 | $828,000 | −$3.5M | −80.82% |
| 2022 | 2022-12-31 | $4.3M | $1.9M | +82.19% |
| 2021 | 2021-12-31 | $2.4M | $1.9M | +420.88% |
| 2020 | 2020-12-31 | $455,000 | $52,000 | +12.90% |
| 2019 | 2019-12-31 | $403,000 | $204,000 | +102.51% |
| 2018 | 2018-12-31 | $199,000 | — | — |
Exagen quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $543,000 | $334,000 | +159.81% |
| Q1 2026 | 2026-03-31 | $228,000 | $115,000 | +101.77% |
| Q4 2025 | 2025-12-31 | $44,000 | −$102,000 | −69.86% |
| Q3 2025 | 2025-09-30 | $275,000 | $128,000 | +87.07% |
| Q2 2025 | 2025-06-30 | $209,000 | $73,000 | +53.68% |
| Q1 2025 | 2025-03-31 | $113,000 | $27,000 | +31.40% |
| Q4 2024 | 2024-12-31 | $146,000 | $40,000 | +37.74% |
| Q3 2024 | 2024-09-30 | $147,000 | $145,000 | +7250.00% |
| Q2 2024 | 2024-06-30 | $136,000 | −$188,000 | −58.02% |
| Q1 2024 | 2024-03-31 | $86,000 | −$310,000 | −78.28% |
| Q4 2023 | 2023-12-31 | $106,000 | −$300,000 | −73.89% |
| Q3 2023 | 2023-09-30 | $2,000 | −$877,000 | −99.77% |
| Q2 2023 | 2023-06-30 | $324,000 | −$1.6M | −83.35% |
| Q1 2023 | 2023-03-31 | $396,000 | −$691,000 | −63.57% |
| Q4 2022 | 2022-12-31 | $406,000 | −$658,000 | −61.84% |
| Q3 2022 | 2022-09-30 | $879,000 | $454,000 | +106.82% |
| Q2 2022 | 2022-06-30 | $1.9M | $1.2M | +172.55% |
| Q1 2022 | 2022-03-31 | $1.1M | $920,000 | +550.90% |
| Q4 2021 | 2021-12-31 | $1.1M | $1.1M | +21180.00% |
| Q3 2021 | 2021-09-30 | $425,000 | $212,000 | +99.53% |
| Q2 2021 | 2021-06-30 | $714,000 | $561,000 | +366.67% |
| Q1 2021 | 2021-03-31 | $167,000 | $83,000 | +98.81% |
| Q4 2020 | 2020-12-31 | $5,000 | −$21,000 | −80.77% |
| Q3 2020 | 2020-09-30 | $213,000 | $211,000 | +10550.00% |
| Q2 2020 | 2020-06-30 | $153,000 | $141,000 | +1175.00% |
| Q1 2020 | 2020-03-31 | $84,000 | −$279,000 | −76.86% |
| Q4 2019 | 2019-12-31 | $26,000 | — | — |
| Q3 2019 | 2019-09-30 | $2,000 | — | — |
| Q2 2019 | 2019-06-30 | $12,000 | — | — |
| Q1 2019 | 2019-03-31 | $363,000 | — | — |
Exagen capital expenditures (capex) trends
Over the last five fiscal years, Exagen's capital expenditures (capex) increased from $455,000 to $641,000, a change of $186,000. The latest reported quarter, Q2 2026, shows $543,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Exagen source filings ↗